Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Benatar

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Immunology, Immunotherapy : CII|December 17, 2009
IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivoTania Benatar, Ming Y Cao, Yoon Lee, et al.
Cancer Immunology, Immunotherapy : CII|May 14, 2005
Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophagesHui Li, Ming Y Cao, Yoon Lee, et al.
Scientific Reports|February 25, 2025
Tuning TCR complex recruitment to the T cell antigen coupler (TAC) enhances TAC-T cell functionTrevor M Morey, Tania Benatar, Stacey X Xu, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2008
Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumorsTania Benatar, Ming Y Cao, Yoon Lee, et al.
International Immunopharmacology|August 4, 2007
Virulizin, a novel immunotherapy agent, stimulates TNFalpha expression in monocytes/macrophages in vitro and in vivoHui Li, Ming Y Cao, Yoon Lee, et al.
Journal of Cancer|October 31, 2015
Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort StudyRobert K Nam, Yutaka Amemiya, Tania Benatar, et al.
Cancer Immunology Research|October 15, 2024
Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2-Positive Solid TumorsStacey X Xu, Ling Wang, Philbert Ip, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Immunology, Immunotherapy : CII|December 17, 2009
IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivoTania Benatar, Ming Y Cao, Yoon Lee, et al.
Cancer Immunology, Immunotherapy : CII|May 14, 2005
Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophagesHui Li, Ming Y Cao, Yoon Lee, et al.
Scientific Reports|February 25, 2025
Tuning TCR complex recruitment to the T cell antigen coupler (TAC) enhances TAC-T cell functionTrevor M Morey, Tania Benatar, Stacey X Xu, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2008
Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumorsTania Benatar, Ming Y Cao, Yoon Lee, et al.
International Immunopharmacology|August 4, 2007
Virulizin, a novel immunotherapy agent, stimulates TNFalpha expression in monocytes/macrophages in vitro and in vivoHui Li, Ming Y Cao, Yoon Lee, et al.
Journal of Cancer|October 31, 2015
Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort StudyRobert K Nam, Yutaka Amemiya, Tania Benatar, et al.
Cancer Immunology Research|October 15, 2024
Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2-Positive Solid TumorsStacey X Xu, Ling Wang, Philbert Ip, et al.
Pageof 2